✦ LIBER ✦

The detection of elevated plasma levels of carcinoembryonic antigen in patients with suspected or established medullary thyroid carcinoma

✍ Scribed by Samuel A. Wells Jr.; Darrow E. Haagensen Jr.; W. Martson Linehan; Ruth E. Farrell; William G. Dilley

Publisher: John Wiley and Sons
Year: 1978
Tongue: English
Weight: 430 KB
Volume: 42
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197809)42:3+<1498::aid-cncr2820420821>3.0.co;2-t

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma carcinoembryonic antigen in the d

Plasma carcinoembryonic antigen in the diagnosis and management of patients with hepatocellular carcinoma

✍ W. M. Melia; P. J. Johnson; Susan Carter; A. Munro-Neville; Roger Williams 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 1 views

Phase I/II trial of 131I-MN-14 F(ab)2 an

Phase I/II trial of 131I-MN-14 F(ab)2 anti–carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma

✍ Malik E. Juweid; George Hajjar; Lawrence C. Swayne; Robert M. Sharkey; Samer Sul 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB

## BACKGROUND. Monoclonal antibodies (MAbs) against carcinoembryonic antigen (CEA) have been recognized as targeting agents for medullary thyroid carcinoma (MTC). This Phase I/II study was initiated to determine the safety, maximum tolerated dose (MTD), and therapeutic potential of 131 I-MN-14 F(ab